JULIE MORANTZ: Open Payments
NPI 1457611667 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 57 payments from 14 companies in 2025. Trend: 2023 $1,663 · 2024 $1,995 · 2025 $1,494
Food & beverage: $1,494
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $244 |
| Edwards Lifesciences Corporation | 1 | $243 |
| Novartis Pharmaceuticals Corporation | 8 | $227 |
| Amgen Inc. | 14 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $170 |
| AstraZeneca Pharmaceuticals LP | 6 | $139 |
| Boston Scientific Corporation | 1 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| PFIZER INC. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
Products named: VERQUVO, SAPIEN 3 Ultra RESILIA, LEQVIO, Repatha, JARDIANCE, FARXIGA, LUX-Dx Insertable Cardiac Monitor, Kerendia.
Industry payments across CA — which companies pay providers there.
